Atlas Trials

Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation

Clinical trial NCT03961256 · COMPLETED

Trial details

NCT number
NCT03961256
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pre Diabetes
Start date
2019-05-09
Primary completion
2021-10-18
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.